Company Description

Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine.

Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains.

The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore.

Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Tivic Health Systems, Inc.

Country	United States
Founded	2016
IPO Date	Nov 11, 2021
Industry	Medical Devices
Sector	Healthcare
Employees	9
CEO	Ms. Jennifer Ernst

Contact Details

Address: 25821 Industrial Blvd., Suite 100 Hayward, California 94545 United States
Phone	(888)276-6888
Website	tivichealth.com

Stock Details

Ticker Symbol	TIVC
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$5.00
CIK Code	0001787740
CUSIP Number	888705100
ISIN Number	US8887052095
Employer ID	81-4016391
SIC Code	3845

Key Executives

Name	Position
Jennifer Ernst	Co-Founder, Chief Executive Officer and Director
Dr. Blake Gurfein Ph.D.	Chief Scientific Officer
Kimberly Ann Bambach	Interim Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Mar 29, 2024	S-1	General form for registration of securities under the Securities Act of 1933
Mar 25, 2024	8-K	Current Report
Mar 25, 2024	10-K	Annual Report
Feb 9, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 1, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024	8-K	Current Report
Nov 14, 2023	10-Q	Quarterly Report
Nov 14, 2023	8-K	Current Report
Sep 26, 2023	8-K	Current Report
Sep 20, 2023	8-K	Current Report

View All SEC Filings